
SHL Telemedicine Ltd. (SHLT) Stock Overview
Explore SHL Telemedicine Ltd.’s financial performance, market position, analyst ratings, and future outlook.
SHL Telemedicine Ltd. (SHLT)
Key Financials
Key Financials
Market Cap
33.6M
P/E Ratio
-1.20
EPS (TTM)
$-0.53
ROE
-0.50%
SHLT Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of SHL Telemedicine Ltd. (NASDAQ: SHLT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, SHL Telemedicine Ltd.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of SHLT on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.
Key metrics behind SHL Telemedicine Ltd.'s NASDAQ-traded stock include a P/E ratio of -1.20 and a market capitalization of 33.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of SHLT on the NASDAQ.